HanchorBio Announces US IND Clearance for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies

HanchorBio Received IND Clearance of HCB101 Multi-regional Clinical Trial By US FDA TAIPEI, TAIWAN and SAN FRANCISCO, CA / ACCESSWIRE / April 17, 2023 / HanchorBio Inc., a global clinical-stage biotechnology company developing innovative immuno-biomedicines, announced today that the US. Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application to initiate […]

Continue Reading

ZeroFox to Acquire LookingGlass, Broadening Global Attack Surface Intelligence Capabilities

Deal strengthens ZeroFox’s External Cybersecurity Platform with industry-leading attack surface management (EASM) and threat intelligence capabilities WASHINGTON, April 17, 2023 (GLOBE NEWSWIRE) — Today, ZeroFox (Nasdaq: ZFOX), an enterprise software-as-a-service leader in external cybersecurity announced a definitive agreement to acquire LookingGlass Cyber Solutions, Inc., a leader in external attack surface management and global threat intelligence. […]

Continue Reading

Apical’s Entry to Sustainable Aviation Fuels Takes Flight with Cepsa to Build the Largest 2G Biofuels Plant in Southern Europe

SINGAPORE – Media OutReach – 17 April 2023 – Apical, through its renewable energy subsidiary Bio-Oils located in Huelva, Spain, has established a joint venture with Cepsa to produce second generation (2G) biofuels by constructing the largest plant in southern Europe. The joint venture will entail an investment of up to €1 billion, one of […]

Continue Reading